DEBM_CompanyBanner_International_LG

Debiopharm International S.A.


developing &
financing
innovative
drugs

Business

Discover our Pipeline

17 programs from discovery to phase III

Discover
Latest news
November 8, 2019

Debiopharm progresses in their stand against drug-resistant N. gonorrhoeae with extended CARB-X funding of their Debio 1453 antibiotic program

Read more
October 9, 2019

A pancreatic and colorectal cancer trial initiated to address the needs of patients with Immune Checkpoint Inhibitor (ICI)-resistant disease by…

Read more
See all news

Business model

Your candidates turned into solutions for patients

In-licensing Deal Focus

You want to partner with us? Discover what kind of projects we look for

Partners
Universities, Biotech, Big pharma
Main areas
Oncology, Infectious Diseases
Development stages
From candidate to clinical phase II
Molecules
Small molecules, antibodies and peptides
Debiopharm-Bertrand-Ducrey
Management

Discover the members who guide and bring long-term vision to the company

Discover
Press releases

Latest Debiopharm International's announcements for media and journalists

Learn more
Publications

Discover Debiopharm International's latest publications and posters

Read more
Contact us

Would like to partner with us? Got a question or a comment? Get in touch!

Get in touch